ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Idaho » Rheumatology

Top Rheumatology Prescribers in Idaho

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIKAEL LAGWINSKI MD

Rheumatology

4,910

$514K

426
323 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $160

CRAIG SCOVILLE MD

Rheumatology

4,904

$727K

290
225 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 25%

$148
Average prescription price

Avg: $160

CRAIG WIESENHUTTER MD

Rheumatology

3,719

$789K

265
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$212
Average prescription price

Avg: $160

JAMES LOVELESS MD

Rheumatology

3,374

$435K

351
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $160

WILLIAM KNIBBE MD

Rheumatology

3,200

$428K

302
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$134
Average prescription price

Avg: $160

AKAVARAM REDDY MD

Rheumatology

2,611

$576K

346
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 25%

$221
Average prescription price

Avg: $160

KELLY TIMMONS M.D. PHD

Rheumatology

2,553

$612K

230
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$240
Average prescription price

Avg: $160

CHARA SOLICH MD

Rheumatology

1,203

$256K

155
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 25%

$213
Average prescription price

Avg: $160

JONATHAN PAINE M.D.

Rheumatology

929

$39.6K

35
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $160

JOHN ADER DO-RHEUMATOLOGY

Rheumatology

646

$114K

125
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$177
Average prescription price

Avg: $160

GREGORY WILSON D.O.

Rheumatology

573

$93.1K

127
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$163
Average prescription price

Avg: $160

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank